adialpharma.com (ADIL) Cash Money per Share

Adial Pharmaceuticals Inc. - graphic logo of issuer ADIL

Adial Pharmaceuticals focuses on bringing an innovative anti-alcoholism treatment to market for individuals with specific genetics. The cash per share metric visualizes asset liquidity, where 10.96 indicates the current level. Massive sales potential and the search for partners are combined with an ESG approach that includes biosafety and a social mission to protect public health.

Adial (ADIL) - Cash per Share from 07/04/2022 to 10/29/2026

Analytical breakdowns for Adial Pharmaceuticals

- cash availability and cash flow indicators:
Summary company analysis:ADIL, Adial Pharmaceuticals, Inc.
Flagship merchandise of Adial Pharmaceuticals

Liquidity provides Adial Pharmaceuticals (ADIL) with the resilience necessary to execute its social mission of combating alcoholism and implementing ESG standards. This metric determines the net amount of cash reserves per share. It is critical for investors to monitor the balance between default protection and capital efficiency. This price action reflects operational flows in real time. Analyzing the history of cash per share allows for an assessment of the company's financial autonomy.